Clinicopathological differences and survival benefit in ER+/PR+/HER2+ vs ER+/PR−/HER2+ breast cancer subtypes Wu DingDengfeng YeChuanjian Tu Original Article 17 January 2024 Pages: 295 - 304
2020 Annual Report of National Clinical Database-Breast Cancer Registry: 10-year mortality of elderly breast cancer patients in Japan Yasuaki SagaraHiraku KumamaruShigehira Saji Special Article 05 January 2024 Pages: 179 - 184
Pilot trial of an electronic patient-reported outcome monitoring system in patients with metastatic breast cancer undergoing chemotherapy Naruto TairaYuichiro KikawaMasataka Sawaki Original Article 04 January 2024 Pages: 283 - 294
The influence of chronic renal insufficiency on multi-therapeutic modalities for breast cancer: a single-center experience Yi-Wen HongI-Ming KuoHsu-Huan Chou Original Article Open access 27 December 2023 Pages: 252 - 262
Radiation-induced angiosarcoma of the breast: retrospective analysis at a regional treatment centre Han Hsi WongElena CojocaruHelen Hatcher Original Article 26 December 2023 Pages: 272 - 282
The Japanese Breast Cancer Society clinical practice guidelines for epidemiology and prevention of breast cancer, 2022 edition Masaaki KawaiShoichiro OhtaniShigehira Saji Special Article Open access 26 December 2023 Pages: 166 - 178
Association of metastatic pattern in breast cancer with tumor and patient-specific factors: a nationwide autopsy study using artificial intelligence Fatemeh KazemzadehJ. A. A. SnoekIris D. Nagtegaal Original Article 22 December 2023 Pages: 263 - 271
Reliability and validity of the Japanese version of the Chemotherapy-induced Alopecia Distress Scale Yosuke AoyamaEri HoshinoHidetaka Kawabata Original Article 11 December 2023 Pages: 234 - 242
Correction: The Japanese breast cancer society clinical practice guidelines for breast cancer screening and diagnosis, 2022 edition Kazunori KubotaKazutaka NakashimaAkihiko Suzuki Correction Open access 11 December 2023 Pages: 165 - 165
Are breast cancer subtypes different in breast cancer patients with and without hepatitis C virus infection? Kadri Altundag Letter to the Editor 09 December 2023 Pages: 155 - 155
Prevalent landscape of tumor genomic alterations of luminal B1 breast cancers using a comprehensive genomic profiling assay in Taiwan Bo-Fang ChenYi-Fang TsaiChi-Cheng Huang Original Article 09 December 2023 Pages: 217 - 227
Annual report of the Japanese Breast Cancer Registry for 2019 Minoru MiyashitaHiraku KumamaruShigehira Saji Special Article 04 December 2023 Pages: 16 - 23
Association of molecular subtypes and treatment with survival in invasive micropapillary breast cancer: an analysis of the Surveillance, Epidemiology, and End Results database Zhenning TangLing LiLingyan Huang Original Article 03 December 2023 Pages: 205 - 216
The effects of breast density on the benefits of mammograms with adjunctive ultrasonography in breast screening Akira NakamuraKoji OhnukiAtsushi Kano Original Article 28 November 2023 Pages: 228 - 233
A novel system to provide information via online YouTube videos and an evaluation of current online information about hereditary breast cancer Asumi IesatoAtsushi FushimiNami Yamashita Original Article Open access 23 November 2023 Pages: 63 - 74
Comment on ‘An increase in tumor-infiltrating lymphocytes after treatment is significantly associated with a poor response to neoadjuvant endocrine therapy for estrogen receptor-positive/HER2-negative breast cancers’ by Fukui et al. Yoshiya Horimoto Letter to the Editor 20 November 2023 Pages: 154 - 154
Medical care costs according to the stage and subtype of breast cancer in a municipal setting: a case study of Hachioji City, Japan Yoshitaka NishikawaNobukazu AgatsumaTakeo Nakayama Original Article Open access 20 November 2023 Pages: 105 - 115
IDO-1 impairs antitumor immunity of natural killer cells in triple-negative breast cancer via up-regulation of HLA-G Rui JingShukun BaiGuoxu Zheng Original Article Open access 19 November 2023 Pages: 135 - 147
Hepatitis C virus may accelerate breast cancer progression by increasing mutant p53 and c-Myc oncoproteins circulating levels Amira FathyMohamed A. AbdelrazekMohamed El-Far Original Article Open access 16 November 2023 Pages: 116 - 123
The Japanese breast cancer society clinical practice guidelines for breast cancer screening and diagnosis, 2022 edition Kazunori KubotaKazutaka NakashimaAkihiko Suzuki Special Article Open access 16 November 2023 Pages: 157 - 164
Fatigue and quality of life during neoadjuvant chemotherapy of early breast cancer: a prospective multicenter cohort study Florian PelzerWilfried TrögerDaniela Paepke Original Article Open access 15 November 2023 Pages: 124 - 134
Machine learning applied in patient-reported outcome research—exploring symptoms in adjuvant treatment of breast cancer Helle PappotBenóný P. BjörnssonCecilie Holländer-Mieritz Rapid Communication 08 November 2023 Pages: 148 - 153
The Japanese breast cancer society clinical practice guidelines for pathological diagnosis of breast cancer, 2022 edition Naoko HonmaMasayuki YoshidaShigehira Saji Special Article Open access 07 November 2023 Pages: 8 - 15
SLC38A5 promotes glutamine metabolism and inhibits cisplatin chemosensitivity in breast cancer Xiaowei ShenGanggang WangWeixing Shen Original Article 02 November 2023 Pages: 96 - 104
Population-level impact of adjuvant trastuzumab emtansine on the incidence of metastatic breast cancer: an epidemiological prediction model of women with HER2-positive early breast cancer and residual disease following neoadjuvant therapy Mellissa WilliamsonDavid J. PressKaustubh Gururaj Original Article Open access 01 November 2023 Pages: 84 - 95
Overall survival in Japanese patients with ER+/HER2− advanced breast cancer treated with first-line palbociclib plus letrozole Masato TakahashiTomofumi OsakoNorikazu Masuda Original Article Open access 26 October 2023 Pages: 53 - 62
Feasibility of accelerated partial breast irradiation with strut-adjusted volume implant brachytherapy in Japan focusing on dosimetry and acute toxicity: a Japanese multi-institutional prospective study Masahiro YoshidaRyo-ichi YoshimuraWorking group of APBI with SAVIs in Japan (WASAVIs) Original Article 21 October 2023 Pages: 75 - 83
The Japanese Breast Cancer Society Clinical Practice Guidelines for surgical treatment of breast cancer, 2022 edition Takehiko SakaiGoro KutomiShigehira Saji Special Article 16 October 2023 Pages: 1 - 7
Psychometric evaluation of the Chinese version of the breast cancer perception scale for community women: a translation and validation study Linghui KongZhen YangHuijun Zhang Original Article 13 October 2023 Pages: 42 - 52
Rethinking screening mammography in Japan: next-generation breast cancer screening through breast awareness and supplemental ultrasonography Takayoshi Uematsu Review Article Open access 12 October 2023 Pages: 24 - 30
Long-term prognostic value of the GenesWell BCT score in Asian women with hormone receptor-positive/HER2-negative early breast cancer Yoshitaka FujikiMasahiro KashiwabaYasuaki Sagara Original Article Open access 09 October 2023 Pages: 31 - 41
The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2022 edition Mitsuo TeradaAki ItoTatsuya Toyama Special Article Open access 07 October 2023 Pages: 872 - 884
Histological spatial analysis on the induction of PD-L1+ macrophages by CD8+ T cells at the marginal microenvironment of triple-negative breast cancer Kazushi SuzukiRintaro OheMitsuru Futakuchi Original Article Open access 04 October 2023 Pages: 1094 - 1104
Predictive factors for response to neoadjuvant chemotherapy: inflammatory and immune markers in triple-negative breast cancer Hiroki KusamaNobuyoshi KittakaTakahiro Nakayama Original Article 02 October 2023 Pages: 1085 - 1093
Preparation, characterization, and in vitro cytotoxicity activity of allyl-isothiocyanate-embedded polymeric nanoparticles for potential breast cancer targeting Prashant Bhagwan PatilJayvadan Kantilal Patel Original Article 11 September 2023 Pages: 1065 - 1078
Glutaminase (GLS1) gene expression in primary breast cancer Neelima VidulaChristina YauHope S. Rugo Original Article 07 September 2023 Pages: 1079 - 1084
Breast cancer-derived exosomal lncRNA SNHG14 induces normal fibroblast activation to cancer-associated fibroblasts via the EBF1/FAM171A1 axis Huaying DongChangcheng YangWei Wang Original Article 31 August 2023 Pages: 1028 - 1040
Immunohistological analysis of B7-H4, IDO1, and PD-L1 expression and tumor immune microenvironment based on triple-negative breast cancer subtypes Fumiaki SanukiYuka MikamiTakuya Moriya Original Article 29 August 2023 Pages: 1041 - 1053
Deep learning model with collage images for the segmentation of dedicated breast positron emission tomography images Tomoki ImokawaYoko SatohUkihide Tateishi Special Feature 27 August 2023
Assessment of nuclear grade-based recurrence risk classification in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative, node-positive high-risk early breast cancer Takeshi MurataMasayuki YoshidaAkihiko Suto Original Article Open access 23 August 2023 Pages: 1054 - 1064
Ex vivo dual gene therapy using human adipocytes secreting anti-HER2 antibody on HER2-positive xenograft tumor models Ryotaro TeranakaHiroshi FujimotoMasayuki Ohtsuka Original Article 23 August 2023 Pages: 1018 - 1027
Reply to “Is venous thromboembolism a time-dependent event in breast cancer patients taking tamoxifen?” Shozo Ohsumi Letter to the Editor 21 August 2023 Pages: 1106 - 1106
Evaluation of quality of life in breast cancer patients who underwent breast-conserving surgery or mastectomy using real-world data Shiao Li OeiAnja ThronickeJessica Groß Original Article 16 August 2023 Pages: 1008 - 1017
MicroRNAs mediated interaction of tumor microenvironment cells with breast cancer cells during bone metastasis R. L. AkshayaI. SaranyaN. Selvamurugan Review Article 14 August 2023 Pages: 910 - 925
Breast cancer screening guidelines: discrepancies raise concerns about validity Nikita JhangianiMegha PhilipIsmail Jatoi Opinion 14 August 2023 Pages: 869 - 871
Pathologic complete response and survival in HER2-low and HER2-zero early breast cancer treated with neoadjuvant chemotherapy Silvia Mihaela IlieNathalie BriotSylvain Ladoire Original Article Open access 10 August 2023 Pages: 997 - 1007
Prognosis of post-neoadjuvant therapy patients who underwent immediate breast reconstruction: a SEER-based, propensity-matched study Jiahao PanLiying PengJian Zhang Original Article Open access 28 July 2023 Pages: 986 - 996
Diagnostic accuracy of pre-operative breast magnetic resonance imaging (MRI) in predicting axillary lymph node metastasis: variations in intrinsic subtypes, and strategy to improve negative predictive value—an analysis of 2473 invasive breast cancer patients Shu-Tian ChenHung-Wen LaiChe-Lun Hung Original Article Open access 27 July 2023 Pages: 976 - 985
Factors associated with non-participation in breast cancer screening: analysis of the 2016 and 2019 comprehensive survey of living conditions in Japan Chitose KawamuraMasao IwagamiNanako Tamiya Original Article 25 July 2023 Pages: 952 - 964